https://www.selleckchem.com/pr....oducts/rhps4-nsc7141
There was no difference in in-hospital mortality, major bleeding, blood transfusion, acute kidney injury, or hospitalization costs for women versus men. At 30days, women continued to show a higher need for pacemaker insertion (11.3% vs 7.1%; P=.03) and had a higher readmission rate than men (10.9% vs 7.1%; P=.02). There was no difference in 30-day mortality between women and men (3% vs 2.4%; P=.54). Among the HCM cohort who received SM, significant sex-based differences in the outcomes were observed. Women had higher new pacemak
Like
Comment
Share
